[go: up one dir, main page]

WO2009073782A3 - Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin - Google Patents

Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin Download PDF

Info

Publication number
WO2009073782A3
WO2009073782A3 PCT/US2008/085530 US2008085530W WO2009073782A3 WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3 US 2008085530 W US2008085530 W US 2008085530W WO 2009073782 A3 WO2009073782 A3 WO 2009073782A3
Authority
WO
WIPO (PCT)
Prior art keywords
proliferative
pelvic
treatment
methods
proliferative agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/085530
Other languages
English (en)
Other versions
WO2009073782A2 (fr
Inventor
Thomas Q. Dinh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AMS Research LLC
Original Assignee
AMS Research LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AMS Research LLC filed Critical AMS Research LLC
Publication of WO2009073782A2 publication Critical patent/WO2009073782A2/fr
Publication of WO2009073782A3 publication Critical patent/WO2009073782A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte sur un dispositif de traitement pelvien pour une administration localisée d'un ou de plusieurs agents antiprolifératifs pour empêcher une croissance et un développement supplémentaire de cellules prolifératives pelviennes mâles ou femelles. Avec l'avantage de leur administration localisée, les agents antiprolifératifs peuvent être introduits dans des cellules prolifératives pelviennes à des taux de dosage inférieurs à ceux qui seraient attendus des mécanismes d'administration du système classique, réduire ou éliminer des effets secondaires ou des états toxiques courants. D'une manière générale, le ou les médicaments antiprolifératifs peuvent être introduits conjointement ou intégralement avec un élément physique qui retient les agents antiprolifératifs pour une libération localisée.
PCT/US2008/085530 2007-12-04 2008-12-04 Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin Ceased WO2009073782A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US99221107P 2007-12-04 2007-12-04
US60/992,211 2007-12-04
US7563308P 2008-06-25 2008-06-25
US61/075,633 2008-06-25

Publications (2)

Publication Number Publication Date
WO2009073782A2 WO2009073782A2 (fr) 2009-06-11
WO2009073782A3 true WO2009073782A3 (fr) 2009-12-30

Family

ID=40718494

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/085530 Ceased WO2009073782A2 (fr) 2007-12-04 2008-12-04 Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin

Country Status (1)

Country Link
WO (1) WO2009073782A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011006067A1 (fr) * 2009-07-09 2011-01-13 Ams Research Corporation Appareil et procédés de traitement d’affections prolifératives pathologiques de tissu utérin

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6086909A (en) * 1997-06-11 2000-07-11 Umd, Inc. Device and method for treatment of dysmenorrhea
US6726923B2 (en) * 2001-01-16 2004-04-27 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20070026042A1 (en) * 2005-07-29 2007-02-01 Narayanan Pallasssana V System for treating aneurysmal disease
US20070049973A1 (en) * 2005-08-29 2007-03-01 Vascular Control Systems, Inc. Method and device for treating adenomyosis and endometriosis
US20070244071A1 (en) * 2006-03-07 2007-10-18 Mount Sinai Hospital Treatment of proliferative diseases

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
US6086909A (en) * 1997-06-11 2000-07-11 Umd, Inc. Device and method for treatment of dysmenorrhea
US6726923B2 (en) * 2001-01-16 2004-04-27 Vascular Therapies, Llc Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US20070026042A1 (en) * 2005-07-29 2007-02-01 Narayanan Pallasssana V System for treating aneurysmal disease
US20070049973A1 (en) * 2005-08-29 2007-03-01 Vascular Control Systems, Inc. Method and device for treating adenomyosis and endometriosis
US20070244071A1 (en) * 2006-03-07 2007-10-18 Mount Sinai Hospital Treatment of proliferative diseases

Also Published As

Publication number Publication date
WO2009073782A2 (fr) 2009-06-11

Similar Documents

Publication Publication Date Title
WO2012034685A3 (fr) Dispositif destiné à être fixé ou interconnecté à un cathéter, cathéter et procédé
MX2020002465A (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros transtornos del tracto urinario inferior.
IL202614A0 (en) Intravaginal drug delivery devices for the delivery of macromolecules and water soluble drugs
WO2007146426A3 (fr) Nanobilles pour délivrance de médicament
WO2008151299A3 (fr) Dispositifs medicaux implantables de traitement local et regional
EP2552356A4 (fr) Composant valvulaire, composant de cadre et dispositif de prothèse valvulaire les comprenant destiné à être implanté dans une lumière corporelle
WO2006053308A3 (fr) Dispositifs et procedes de distribution d'energie amelioree
WO2011041221A3 (fr) Cartouche de traitement d'eau
WO2009048594A3 (fr) Anneau vaginal bioactif renfermant plusieurs composants
EP2019646A4 (fr) Méthode, dispositif et système d'administration de substances thérapeutiques dans l'oeil
WO2006053309A3 (fr) Dispositifs et methodes ameliores d'apport d'energie
WO2009031606A1 (fr) Agents thérapeutiques et prophylactiques pour l'arthrite
WO2012011109A3 (fr) Procédé de traitement de l'incontinence urinaire
MX2016011333A (es) Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina.
WO2009073307A3 (fr) Dispositifs médicaux implantables pour traitement local ou zonal
NZ592049A (en) Compositions and methods for the treatment of bowel diseases with granulated mesalamine
WO2014036556A3 (fr) Systèmes d'administration de médicaments et méthodes de traitement du cancer de la prostate
MX2012007234A (es) Nanocristales de monohidrato de calciprotiol.
BR112012013011A2 (pt) odt; composição de odt; método para a preparação de um tablete de odt multiparticulado, método para tratar ou prevenir náusea e vômito pós operatória ou náusea e vômito pós- alta por até 24 horas após a dosagem, método para tratar pu prevenir náusea por até 24 horas após a dosagem e método para tratar ou prevenir náusea e vômito associados a radioterapia em pacientes que recebem ou irradiação de corpo total, dose alta única ao abdômen, ou frações diárias ao abdômen por até 24 horas após a dosagem
WO2009073782A3 (fr) Appareil et procédés de traitement d'états prolifératifs pathologiques du tissu utérin
WO2009111681A3 (fr) Composés de gallium et procédés d’utilisation pour traiter les maladies inflammatoires chroniques de l’intestin
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
MX2010003615A (es) Tratamiento de desordenes neurologicos.
TN2015000156A1 (en) Dispersible tablet
TW200738229A (en) Memantine for the normalization of visual acuity deficits

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08856678

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08856678

Country of ref document: EP

Kind code of ref document: A2